Melanoma subtypes demonstrate distinct PD-L1 expression profiles

PD-L1 expression in the tumor immune microenvironment is recognized as both a prognostic and predictive biomarker in patients with cutaneous melanoma, a finding closely related to its adaptive (IFN-γ-mediated) mechanism of expression. Approximately 35% of cutaneous melanomas express PD-L1, however,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Lab Invest
Asıl Yazarlar: Kaunitz, Genevieve J, Cottrell, Tricia R, Lilo, Mohammed, Muthappan, Valliammai, Esandrio, Jessica, Berry, Sneha, Xu, Haiying, Ogurtsova, Aleksandra, Anders, Robert A, Fischer, Alexander H, Kraft, Stefan, Gerstenblith, Meg R, Thompson, Cheryl L, Honda, Kord, Cuda, Jonathan D, Eberhart, Charles G, Handa, James T, Lipson, Evan J, Taube, Janis M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5685163/
https://ncbi.nlm.nih.gov/pubmed/28737763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/labinvest.2017.64
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller